We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
Cap. Flow
+$1.69B
Cap. Flow %
19.13%
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175

Top Buys

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$78.4M
2
INFY icon
Infosys
INFY
+$65M
3
FFIV icon
F5
FFIV
+$64.6M
4
WDC icon
Western Digital
WDC
+$62.1M
5
CI icon
Cigna
CI
+$60.1M

Top Sells

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$69.1M
2
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$68.2M
3
PCYC
PHARMACYCLICS INC
PCYC
+$57.6M
4
MDT icon
Medtronic
MDT
+$51.8M
5
DRC
DRESSER-RAND GROUP INC
DRC
+$50.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.28%
2 Healthcare 13.44%
3 Technology 12.36%
4 Financials 10.47%
5 Energy 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
326
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.55M 0.03%
+15,625
New +$2.65M
CMI icon
327
Cummins
CMI
$88.7B
$2.47M 0.03%
18,853
-80,927
-81% -$11.1M
TRVN
328
DELISTED
Trevena, Inc.
TRVN
$2.45M 0.03%
626
+10
+2% +$42.3K
STLD icon
329
Steel Dynamics
STLD
$37.6B
$2.45M 0.03%
118,078
-814,668
-87% -$17.5M
FSB
330
DELISTED
Franklin Financial Network, Inc.
FSB
$2.42M 0.03%
105,701
-19,299
-15% -$414K
CVLG icon
331
Covenant Logistics
CVLG
$872M
$2.41M 0.03%
+192,142
New +$2.93M
ADAP
332
DELISTED
Adaptimmune Therapeutics
ADAP
$2.38M 0.03%
+129,853
New +$2.23M
CMC icon
333
Commercial Metals
CMC
$8.31B
$2.38M 0.03%
+147,825
New +$2.41M
CYBR
334
DELISTED
CyberArk
CYBR
$2.24M 0.03%
+35,600
New +$2.28M
RLYP
335
DELISTED
RELYPSA INC COM
RLYP
$2.23M 0.03%
67,457
+26,998
+67% +$928K
LENS
336
DELISTED
Presbia PLC Ordinary Shares
LENS
$2.22M 0.03%
270,287
+4,377
+2% +$35.9K
DERM
337
DELISTED
Dermira, Inc.
DERM
$2.22M 0.03%
126,541
+2,049
+2% +$31.6K
BOH icon
338
Bank of Hawaii
BOH
$3.13B
$2.19M 0.02%
32,894
-180,868
-85% -$11.4M
PETX
339
DELISTED
Aratana Therapeutics, Inc.
PETX
$2.17M 0.02%
143,252
+80,712
+129% +$1.17M
META icon
340
CALL
Meta Platforms (Facebook)
META
$1.51T
$2.14M 0.02%
25,000
-225,000
-90% -$18.4M
RICE
341
DELISTED
Rice Energy Inc.
RICE
$2.14M 0.02%
+102,715
New +$2.33M
EIGI
342
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$2.12M 0.02%
102,694
-147,306
-59% -$3.07M
VNDA icon
343
Vanda Pharmaceuticals
VNDA
$302M
$2.08M 0.02%
163,676
-38,540
-19% -$416K
WTFC icon
344
Wintrust Financial
WTFC
$10.7B
$2.06M 0.02%
+38,498
New +$1.94M
LKFT
345
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$2.02M 0.02%
+39,320
New +$2.09M
UPLD icon
346
Upland Software
UPLD
$15.4M
$2.02M 0.02%
21,942
+355
+2% +$26.2K
ENV
347
DELISTED
ENVESTNET, INC.
ENV
$2.02M 0.02%
+50,000
New +$2.41M
BPMC
348
DELISTED
Blueprint Medicines
BPMC
$2.02M 0.02%
+76,235
New +$2.18M
CNCE
349
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.01M 0.02%
135,261
+5,261
+4% +$80.1K
NVTA
350
DELISTED
Invitae Corporation
NVTA
$1.97M 0.02%
132,140
+2,140
+2% +$30.4K
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2015 Portfolio in Review

As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.

  • Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
  • Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
  • Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
  • Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
  • Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
  • Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.